Citadel Advisors - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V907. A total of 3 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2016$212,000
-63.6%
7,100
-64.1%
0.00%
-100.0%
Q1 2016$582,000
-39.1%
19,800
+62.3%
0.00%0.0%
Q4 2015$956,000
+30.8%
12,200
+25.8%
0.00%0.0%
Q3 2015$731,000
-64.2%
9,700
-44.6%
0.00%
-50.0%
Q2 2015$2,043,000
-50.3%
17,500
+0.6%
0.00%
-50.0%
Q1 2015$4,108,000
-18.1%
17,400
-34.3%
0.00%
-20.0%
Q4 2014$5,016,000
-24.9%
26,500
-5.4%
0.01%
-28.6%
Q3 2014$6,680,000
+484.9%
28,000
+61.8%
0.01%
+600.0%
Q2 2014$1,142,000
-44.0%
17,300
-11.7%
0.00%
-50.0%
Q1 2014$2,041,00019,6000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2014
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 462$474,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 24,600$252,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders